PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

107 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
81.
Herder, C.* et al.: Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care 36, 3663-3870 (2013)
82.
Icks, A.* et al.: Drug costs in prediabetes and undetected diabetes compared with diagnosed diabetes and normal glucose tolerance: Results from the population-based KORA survey in Germany. Diabetes Care 36, 53-54 (2013)
83.
Lehmann, R.* et al.: Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36, 2331-2338 (2013)
84.
Marzi, C. et al.: Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care 36, 1321-1326 (2013)
85.
Bongaerts, B.W.C.* et al.: Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: The KORA F4 study. Diabetes Care 35, 1891-1893 (2012)
86.
de Miguel-Yanes, J.M.* et al.: Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34, 121-125 (2011)
87.
Hummel, S. ; Pflüger, M. ; Hummel, M. ; Bonifacio, E.* & Ziegler, A.-G.: Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: The BABYDIET study. Diabetes Care 34, 1301-1305 (2011)
88.
Meisinger, C. et al.: Retinol-binding protein 4 is associated with prediabetes in adults from the general population: The Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes Care 34, 1648-1650 (2011)
89.
Schlosser, M.* et al.: Diabetes antibody standardization program: First evaluation of assays for autoantibodies to IA-2β. Diabetes Care 34, 2410-2412 (2011)
90.
Thorand, B. et al.: Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: Results from the MONICA/KORA Augsburg study. Diabetes Care 34, 2320-2322 (2011)
91.
Boerschmann, H.* ; Pflüger, M. ; Henneberger, L. ; Ziegler, A.-G. & Hummel, S.: Prevalence and predictors of overweight and insulin resistance in offspring of mothers with gestational diabetes mellitus. Diabetes Care 33, 1845-1849 (2010)
92.
Hahn, V. et al.: Physical activity and the metabolic syndrome in elderly German men and women: Results from the population-based KORA survey. Diabetes Care 32, 511-513 (2009)
93.
Herder, C.* et al.: Transforming growth factor-β1 and incident type 2 diabetes: Results from the MONICA/KORA case-cohort study, 1984-2002. Diabetes Care 32, 1921-1923 (2009)
94.
Herder, C.* et al.: Subclinical inflammation and diabetic polyneuropathy. Diabetes Care 32, 680-682 (2009)
95.
Brandstatter, A.* et al.: Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 31, 1662-1667 (2008)
96.
Ziegler, D.* ; Rathmann, W.* ; Dickhaus, T.* ; Mielck, A. & KORA Study Group (Meisinger, C. ; Wichmann, H.-E. ; Holle, R. ; John, J. ; Illig, T. ; Peters, A.): Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31, 464-469 (2008)
97.
Ziegler, D.* et al.: Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: The MONICA/KORA Augsburg Cohort Study. Diabetes Care 31, 556-561 (2008)
98.
Kuch, B.* et al.: Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: The Augsburg Diabetes Family Study. Diabetes Care 30, 946-952 (2007)
99.
Thorand, B. et al.: Sex differences in the prediction of type 2 diabetes by inflammatory markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30, 854-860 (2007)
100.
Herder, C.* et al.: Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29, 368-371 (2006)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮